Correlation Between Tarsus Pharmaceuticals and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Design Therapeutics, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Design Therapeutics.
Diversification Opportunities for Tarsus Pharmaceuticals and Design Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Tarsus and Design is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Design Therapeutics go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Design Therapeutics
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.53 times more return on investment than Design Therapeutics. However, Tarsus Pharmaceuticals is 1.9 times less risky than Design Therapeutics. It trades about -0.15 of its potential returns per unit of risk. Design Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 5,200 in Tarsus Pharmaceuticals on October 20, 2024 and sell it today you would lose (548.00) from holding Tarsus Pharmaceuticals or give up 10.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Design Therapeutics
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Design Therapeutics |
Tarsus Pharmaceuticals and Design Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Design Therapeutics
The main advantage of trading using opposite Tarsus Pharmaceuticals and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
| Design Therapeutics vs. Agilent Technologies | Design Therapeutics vs. Equillium | Design Therapeutics vs. 23Andme Holding Co | Design Therapeutics vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |